Merican School of Medical Genetics Board of Administrators: Points to think about > 커뮤니티 카카오소프트 홈페이지 방문을 환영합니다.

Merican College of Medical Genetics Marimastat Board of Administrators: Points to take into account: moral, legal, and psychosocial implications of genetic tests in children and adolescents. Am J Hum Genet 1995, fifty seven:1233?241. 102. Bernard R, Boyer A, Negre P, Malzac P, Latour P, Vandenberghe A, Philip N, Levy N: Prenatal detection of your 17p11.two duplication in Charcot-MarieTooth ailment form 1A: requirement of the multidisciplinary method for heterogeneous ailments. Eur J Hum Genet 2002, ten:297?02. 103. Goossens V, Traeger-Synodinos J, Coonen E, De Rycke M, Moutou C, Pehlivan T, Derks-Smeets IA, Harton G: ESHRE PGD Consortium details selection XI: cycles from January to December 2008 with pregnancy follow-up to Oct 2009. Hum Reprod 1887?911, 2012:27. 104. Harper JC, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C, SenGupta SB, Pehlivan Budak T, Renwick P, De Rycke M, Geraedts JP, Harton G: The ESHRE PGD Consortium: 10 decades of data selection. Hum Reprod Update 2012, 18:234?47. one hundred and five. Younger P, De Jonghe P, Stogbauer F, Butterfass-Bahloul T: Therapy for Charcot-Marie-Tooth illness. Cochrane Database Syst Rev 2008, one:CD006052. 106. Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hoppitt T: Rehabilitation interventions for foot drop in neuromuscular disorder. Cochrane Databases Syst Rev 2009, 3:CD003908. 107. Guyton GP, Mann RA: The pathogenesis and surgical administration of foot deformity in Charcot-Marie-Tooth sickness. Foot Ankle Clin 2000, five:317?26. 108. Ward CM, Dolan LA, Bennett DL, Morcuende JA, Cooper RR: Long-term effects of reconstruction for procedure of the versatile cavovarus foot in Charcot-Marie-Tooth disorder. J Bone Joint Surg Am 2008, ninety:2631?642. 109. Leeuwesteijn AE, De Visser E, Louwerens JW: Versatile cavovarus toes in Charcot-Marie-Tooth disorder handled with very first ray proximal dorsiflexion osteotomy coupled with gentle tissue medical procedures: a short-term to mid-term outcome examine. Foot Ankle Surg 2010, sixteen:142?47. one hundred ten. Videler A, Eijffinger E, Nollet F, Beelen A: A thumb opposition splint to boost manual dexterity and upper-limb functioning in Charcot-MarieTooth disorder. J Rehabil Med 2012, 44:249?53. 111. Wooden VE, Huene D, Nguyen J: Treatment method in the upper limb in CharcotMarie-Tooth disease. J Hand Surg [Br ] 1995, twenty:511?18. 112. Brown RE, Zamboni WA, Zook EG, Russell RC: Evaluation and administration of higher extremity neuropathies in Charcot- Marie-Tooth disorder. J Hand Surg [Am ] 1992, 17:523?30. 113. Sheth S, Francies K, Siskind CE, Feely SM, Lewis RA, Shy ME: Diabetic issues mellitus exacerbates motor and sensory impairment in CMT1A. J Peripher Nerv Syst 2008, thirteen:299?04.114. Ursino G, Alberti MA, Grandis M, Reni L, Pareyson D, Bellone E, Gemelli C, Sabatelli M, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22316373 Pisciotta C, Luigetti M, Santoro L, Massollo L, Schenone A: Influence of comorbidities around the phenotype of people afflicted by Charcot-Marie-Tooth neuropathy type 1A. Neuromuscul Disord 2013, 23:902?06. one hundred fifteen. Weimer LH, Podwall D: Medication-induced exacerbation of neuropathy in Charcot Marie Tooth sickness. J Neurol Sci 2006, 242:forty seven?four. 116. Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Hen TD: Extreme vincristine neuropathy in Charcot-Marie-Tooth disease style 1A. Cancer 1996, seventy seven:1356?362. 117. Hildebrandt G, Holler E, Woenkhaus M, Quarch G, Reichle A, Schalke B, Andreesen R: Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9547713 of vincristine chemotherapy. Ann Oncol 2000, eleven:743?47. 118. Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDerm.